The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABBVIE INC | COM | 00287Y109 | 88 | 1,000 | SH | SOLE | 1,000 | 0 | 0 | ||
| ALKERMES PLC | SHS | G01767105 | 77,622 | 3,805,000 | SH | SOLE | 3,805,000 | 0 | 0 | ||
| ALLERGAN PLC | SHS | G0177J108 | 89,371 | 467,500 | SH | SOLE | 467,500 | 0 | 0 | ||
| BIOGEN INC | COM | 09062X103 | 190,797 | 643,000 | SH | SOLE | 643,000 | 0 | 0 | ||
| INNOVIVA INC | COM | 45781M101 | 88,386 | 6,242,000 | SH | SOLE | 6,242,000 | 0 | 0 | ||
| INTERCEPT PHARMACEUTICALS INC | COM | 45845P108 | 106,571 | 860,000 | SH | SOLE | 860,000 | 0 | 0 | ||
| IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | 137,186 | 10,307,000 | SH | SOLE | 10,307,000 | 0 | 0 | ||
| JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | 66,205 | 443,500 | SH | SOLE | 443,500 | 0 | 0 | ||
| MEDICINES CO | COM | 584688105 | 356,917 | 4,202,000 | SH | SOLE | 4,202,000 | 0 | 0 | ||
| MEDICINES CO | NOTE 3.500% 1/1 | 584688AJ4 | 68,377 | 20,000,000 | PRN | SOLE | 20,000,000 | 0 | 0 | ||
| MERSANA THERAPEUTICS INC | COM | 59045L106 | 21,487 | 3,750,000 | SH | SOLE | 3,750,000 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 128 | 1,000 | SH | SOLE | 1,000 | 0 | 0 | ||
| REGULUS THERAPEUTICS INC | COM NEW | 75915K200 | 1,648 | 1,851,851 | SH | SOLE | 1,851,851 | 0 | 0 | ||